Executive Summary

GrafTech International ($7.01, market cap $183M) is a distressed pure-play graphite electrode producer carrying $1.125B in debt against negative EBITDA. The stock has collapsed 60% in the past month after a catastrophic Q4 2025 earnings miss. The company is selling its product at or below cash cost, burning ≈$120M/yr in cash, and management refused to provide 2026 pricing guidance — the clearest possible bearish signal on their core business.

The bull case rests entirely on trade policy: anti-dumping tariffs on Chinese anode material, critical mineral designation for synthetic graphite, Section 232 steel tariff tailwinds, and a nascent pivot to battery anode material via GrafTech's Seadrift synthetic graphite facility. Competitor capacity rationalization (Resonac -70K MT, Tokai Carbon -34K MT) provides a secondary catalyst.

Our assessment: This is a lottery ticket, not an investment. The expected value is marginally positive due to asymmetric upside, but the median outcome is negative. The trade policy catalysts are real but target adjacent markets (anode material, not electrodes). Insider buying is negligible — two directors purchased ≈$81K combined in May 2025, with nothing since. The equity is a deeply out-of-the-money call option on either a massive pricing recovery or a strategic transaction, with a 2.5-year fuse before the debt wall arrives.

The Financial Reality

The numbers are unambiguous. GrafTech is bleeding out.

FY 2025 Results (per 8-K, Feb 6, 2026):

• Revenue: $504M | COGS: $501M — essentially zero gross margin
• Net loss: $220M ($8.45/share) | Adj EBITDA: -$9M
• Interest expense: $104M/yr on $1.125B gross debt
• Cash burned: $118M ($256M → $138M)
• Full valuation allowance established on $43M deferred tax assets — the accounting team does not expect this company to be profitable

Q4 2025 specifically:

• Net loss $65M ($2.50/share) vs consensus -$1.16 — a 112% miss
• Adj EBITDA: -$22M
• ASP: $4,000/MT (down 9% YoY, 5% sequentially)
• Cash COGS: $4,019/MT (Q4), ≈$3,800/MT (full year)

The company is selling electrodes at or below cash cost. Revenue has collapsed from $1.35B (FY2021) to $504M (FY2025). Stockholders' deficit widened from -$79M to -$260M. This is a company where the liabilities exceed the assets by a quarter billion dollars.

The Liquidity Clock

Total liquidity: $340M as of year-end 2025.

• $138M cash
• $102M revolver availability (springing financial covenant limits access)
• $100M undrawn delayed-draw term loan (available until July 2026)

At ≈$120M/yr cash burn, that is approximately 2.5-3 years of runway — conveniently aligned with the December 2029 debt maturity wall when $1.125B comes due simultaneously. The math is simple: either the business fundamentally improves before then, or bondholders take the keys.

Warning on trajectory: Full-year Adj EBITDA was -$9M, but Q4 alone was -$22M — the deterioration is accelerating. If Q4's run-rate persists, annual EBITDA could be -$80M+, roughly doubling the cash burn rate and cutting the runway in half.

2026 cash flow estimate: At current negative EBITDA (-$9M), plus ≈$104M interest + $35M capex = ≈$148M cash outflows. Drawing the $100M delayed-draw reduces the net burn to ≈$48M, potentially ending 2026 with ≈$90M cash. Any pricing deterioration accelerates the countdown.

Debt Structure

The December 2024 exchange was expertly executed — 99%+ participation, extending maturities to 2029:

*Springing maturity 91 days before reference indebtedness. The revolver has a 4.00x senior secured leverage covenant that currently limits borrowing capacity.

Key covenant: New Notes restrict payments when leverage exceeds 2.50x. At negative EBITDA, leverage is effectively infinite — the company cannot repurchase shares, pay dividends, or make restricted payments.

The Electrode Market: Structural Overcapacity

CEO Timothy Flanagan was blunt: "It is not the level of electrode demand that is the key factor... it is the supply side imbalance that is ultimately driving pricing."

The global graphite electrode market outside China has approximately 900K-1M MT of demand. Supply vastly exceeds this:

• Chinese exports: >300K MT total, 200-250K MT ultra-high power (UHP). China has ≈800K MT of domestic capacity for ≈90M MT of EAF steel — massively overbuilt. Chinese exports represent roughly one-third of the entire non-Chinese market.
• Indian expansion: HEG Ltd reported record quarterly profits in Q3 FY26 (revenue +37% YoY). Graphite India returned to profitability. Both are expanding capacity. Indian producers thrive at prices that are destroying GrafTech.
• Irrational pricing: Flanagan called competitor behavior "increasingly aggressive and arguably irrational." Prices below cash cost do not incentivize R&D, maintenance capex, or shareholder returns. The industry is in a death spiral where the weakest players bleed cash while low-cost producers (India, China) capture share.

The Rationalization Signal

Here is the one genuinely bullish development in the electrode market:

Resonac (formerly Showa Denko) announced in 2025 that it is closing graphite electrode plants in China (Sichuan) and Malaysia (Banting), removing approximately 70K MT/yr — one-third of its 210K MT global capacity. Headcount is being cut 40% (≈700 employees). Expected annual savings: JPY 11.7B (≈$78M). Remaining operations: Japan, US, Austria, Spain.

Tokai Carbon is mothballing its Shiga plant in Japan, reducing capacity from 56K to 32K MT, with ≈30% cuts in Europe (30K → 20K MT). Combined Tokai reduction: ≈34K MT.

Total rationalization: ≈104K MT removed from the ex-China market. That is 5-7% of non-Chinese supply — meaningful, but probably insufficient while Chinese exports at 300K+ MT remain the dominant oversupply factor.

SGL Carbon has already exited the graphite electrode business entirely, focusing on specialty graphite and carbon fibers. GrafTech is now the only pure-play electrode producer outside India and China.

Trade Policy: The Catalyst Menu

Anti-Dumping on Chinese Anode Material (160% total tariff)

The US Commerce Department imposed preliminary anti-dumping duties of 93.5% on Chinese active anode material (AAM) imports, bringing the total effective tariff to ≈160% when combined with countervailing duties (11.5%), blanket tariffs (30%), and Section 301 tariffs (25%).

Timeline: ITC hearing was held February 12, 2026 (today). Final release of information expected March 5. Final ITC determination expected late March 2026.

Critical distinction: These tariffs apply to battery anode material, not graphite electrodes. GrafTech's core electrode business receives zero direct protection from this action. The relevance is indirect — GrafTech's Seadrift facility in Port Lavaca, TX produces synthetic graphite from petroleum needle coke, which could theoretically supply domestic anode material to battery manufacturers shut off from Chinese supply.

CEO Flanagan acknowledged the company cannot pursue this opportunity alone: "This is not an area where GrafTech is going to be able to make multibillion-dollar investments on a standalone basis." Any anode revenue would require partnerships. No partners have been named. No timeline has been given. This remains early-stage.

Section 232 Steel Tariffs (50%, No Exemptions)

The expansion of Section 232 steel tariffs from 25% to 50% in June 2025, with zero exemptions, has driven foreign steel imports to 30-year lows. Per Nucor's Q4 2025 commentary, import share of finished steel dropped from ≈25% in early 2025 to an estimated 14% by November 2025. Nucor CEO: "These are import levels we haven't seen in 30 years."

This directly benefits electrode demand. More domestic steel production means more EAF steelmaking means more electrode consumption. The US has 20M+ tons of new EAF capacity recently online or planned. ArcelorMittal announced plans to double EAF capacity at Calvert, Alabama.

GrafTech has aggressively shifted toward the US market — US sales grew 48% full-year and 83% in Q4. The US now represents 31% of sales volume (vs 22% in 2024), and US pricing carries a ≈$200/MT premium.

This is the most tangible catalyst. Higher US electrode demand + US pricing premium + geographic shift = partially mitigates global pricing collapse. But it is not enough alone to restore profitability.

Critical Minerals & Section 232 Proclamation

On January 14, 2026, President Trump issued a Section 232 proclamation on processed critical minerals. Graphite is on the critical minerals list. However:

• No tariffs were imposed at this time
• Instead, a 180-day negotiation period was initiated (deadline July 13, 2026)
• If negotiations fail, tariffs or price floors may follow
• No specific carve-out for synthetic graphite

Separately, Project Vault was announced February 3, 2026: a $10B Ex-Im Bank loan + ≈$2B private capital to create a strategic critical mineral stockpile. Graphite is included among 50+ covered minerals. GrafTech's Seadrift is one of very few US synthetic graphite facilities. But procurement details are absent — unclear if electrodes vs anode material vs raw graphite would be purchased.

EU CBAM

The Carbon Border Adjustment Mechanism entered into force January 1, 2026, covering steel imports into the EU. Graphite electrodes are not directly covered, but reduced Chinese steel competitiveness in Europe should boost domestic EU production and electrode demand. GrafTech operates plants in France and Spain. Full financial impact on electrodes is expected to be modest and gradual (2027-2028 timeframe for full implementation).

The Negative: Indian Tariff Cut

Largely unreported but materially bearish: US tariffs on Indian imports were cut from 50% to 18%. CEO Flanagan called this "probably a step too far." India is adding electrode capacity while benefiting from a lower tariff barrier into the US market — GrafTech's highest-priced and most strategically important region.

Cross-Ticker Context

The steel sector provides important context:

• Nucor (NUE, $190): Backlogs up 40% YoY. 95% of data center steel demand. Section 232 driving imports to 30-year lows. $2.5B capex in 2026. The EAF steelmaking buildout is real.
• Steel Dynamics (STLD, $199): Strong momentum (+52% 1Y). Diversifying into aluminum. US sheet market healthy.
• Cleveland-Cliffs (CLF, $10.81, -13% today): Full-year 2025 net loss of $1.48B. Revenue missed by $300M. Cliffs demonstrates that even tariff-protected steel can struggle when demand softens. Insider selling.

The steel demand side of GrafTech's equation is genuinely improving. But CEO Flanagan was explicit: demand is not the problem. Supply is. Steel producers are thriving while their electrode supplier bleeds out — a "disconnect between value creation in the steel industry and the pricing environment for graphite electrodes," as Flanagan put it.

Valuation Framework

GrafTech's equity has no intrinsic value on current fundamentals. Negative EBITDA, negative book value, $1.125B in debt. The stock is a call option on regime change — either in pricing or in corporate structure.

Scenario Analysis:

Expected value: ~+17%. Marginally positive due to asymmetric upside in the bull case. But the median outcome (80th percentile) is flat-to-down. Risk of permanent capital loss is material.

What would change the thesis:

• Electrode-specific anti-dumping case against Chinese/Indian producers (does not exist)
• Named anode material partnership with revenue timeline
• Additional competitor capacity closures (beyond Resonac/Tokai)
• ASP recovery above $4,500/MT on sustained basis
• Management drawing delayed-draw term loan (signals cash need or investment)

What kills it:

• ASP declines below $3,800/MT (below cash cost = accelerating cash burn)
• Revolver access further restricted by covenant (springing covenant risk)
• Indian capacity coming online faster than expected with 18% tariff access to US
• No electrode-specific tariff protection materializes
• Partnership announcements remain absent through 2026
• Dilutive equity raise or debt-for-equity conversion — management's language about "strategic partnerships and sources of capital" should be read as a warning; a $100M raise at $5 would dilute shares ≈55%

The Honest Assessment

The trade policy story around GrafTech is seductive but misunderstood. The 160% tariff on Chinese anode material protects the battery supply chain, not the electrode supply chain. There is no pending anti-dumping case on graphite electrodes themselves. The critical mineral designation includes graphite broadly but has produced no tariffs. Section 232 on critical minerals deferred action for 180 days of negotiations.

GrafTech's real competitive advantage is its position as the only pure-play electrode producer with Western manufacturing (US, France, Spain). If trade policy eventually catches up to electrodes — or if anode material partnerships materialize — the stock is worth multiples of the current price. If it doesn't, this is a company burning through its liquidity cushion en route to a debt restructuring.

Insider buying is de minimis — two directors purchased ≈$81K combined in May 2025, nothing since. No analyst rates it a buy. The options market is too illiquid to provide signal. Short interest is a negligible 2.3%.

For position sizing: This is a sub-1% position at most — a defined-risk call option on trade policy escalation. The October 2025 Section 232 report + January 2026 proclamation + AAM tariff finalization (March 2026) + 180-day negotiation deadline (July 2026) provide a catalyst timeline. If nothing materializes by late 2026, the thesis is dead and the clock is ticking.

The competitor rationalization (104K MT removed) is the one structural positive that could improve pricing independently of policy. But Indian expansion and Chinese exports must slow simultaneously. At current trajectory, this company has 2.5 years of cash and a decade of problems.

Data as of February 12, 2026. Price: $7.01. Sources: EAF 8-K (Feb 6, 2026), 10-K (Feb 14, 2025), Q4 2025 earnings transcript, Commerce.gov, Federal Register, Nikkei Asia, NUE/STLD/CLF earnings, yfinance.